Literature DB >> 10875439

Copper catalyzed oxidation of Alzheimer Abeta.

C S Atwood1, X Huang, A Khatri, R C Scarpa, Y S Kim, R D Moir, R E Tanzi, A E Roher, A I Bush.   

Abstract

Abeta derived from amyloid plaques of Alzheimer's disease-affected brain contain several oxidative posttranslational modifications. In this study we have characterized the amino acid content of human amyloid-derived Abeta and compared it with that of human synthetic Abeta subjected to metal-catalyzed oxidation. Human amyloid derived Abeta has an increased content of arginine (46%) and glutamate/glutamine residues (28%), but a decreased content of histidine residues (-32%) as compared to the expected amino acid content. Incubation of synthetic human Abeta with Cu(II), but not Fe(III), in the presence of H2O2 similarly induced a decrease in histidine residues (-79%), but also a decrease in tyrosine residues (-28%). Our results suggest that histidine and tyrosine are most vulnerable to metal mediated oxidative attack, consistent with our earlier findings that Cu coordinated via histidine residues is redox competent. Our results suggest that the loss of histidine residues in human amyloid-derived Abeta may be a result of Cu oxidation, and that unidentified post-translational mechanisms operate to modify other amino acids of Abeta in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10875439

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  19 in total

Review 1.  Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer's disease.

Authors:  Mark P Mattson
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

2.  Copper, beta-amyloid, and Alzheimer's disease: tapping a sensitive connection.

Authors:  Ashley I Bush; Colin L Masters; Rudolph E Tanzi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-23       Impact factor: 11.205

3.  PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42.

Authors:  Olivier Boutaud; Thomas J Montine; Lei Chang; William L Klein; John A Oates
Journal:  J Neurochem       Date:  2006-01-12       Impact factor: 5.372

Review 4.  An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels.

Authors:  Xiaoling Zhou; Yifei Li; Xiaozhe Shi; Chun Ma
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

5.  Identification of 2-oxohistidine Interacting Proteins Using E. coli Proteome Chips.

Authors:  Jun-Mu Lin; Yu-Ting Tsai; Yu-Hsuan Liu; Yun Lin; Hwan-Ching Tai; Chien-Sheng Chen
Journal:  Mol Cell Proteomics       Date:  2016-09-19       Impact factor: 5.911

Review 6.  Alzheimer's disease & metals: therapeutic opportunities.

Authors:  Vijaya B Kenche; Kevin J Barnham
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

7.  Capturing a reactive state of amyloid aggregates: NMR-based characterization of copper-bound Alzheimer disease amyloid β-fibrils in a redox cycle.

Authors:  Sudhakar Parthasarathy; Brian Yoo; Dan McElheny; William Tay; Yoshitaka Ishii
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

8.  The Aggregation Paths and Products of Aβ42 Dimers Are Distinct from Those of the Aβ42 Monomer.

Authors:  Tiernan T O'Malley; William M Witbold; Sara Linse; Dominic M Walsh
Journal:  Biochemistry       Date:  2016-10-26       Impact factor: 3.162

9.  Endogenous zinc in neurological diseases.

Authors:  Jae-Yong Koh
Journal:  J Clin Neurol       Date:  2005-10-20       Impact factor: 3.077

10.  Chronic exposure to high levels of zinc or copper has little effect on brain metal homeostasis or Abeta accumulation in transgenic APP-C100 mice.

Authors:  Christa J Maynard; Roberto Cappai; Irene Volitakis; Katrina M Laughton; Colin L Masters; Ashley I Bush; Qiao-Xin Li
Journal:  Cell Mol Neurobiol       Date:  2009-04-21       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.